2020
DOI: 10.3390/antibiotics9050260
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Biosynthesized ZnO Nanoparticles on Multi-Drug Resistant Pseudomonas Aeruginosa

Abstract: Synthesis of nanoparticles using the plants has several advantages over other methods due to the environmentally friendly nature of plants. Besides being environmentally friendly, the synthesis of nanoparticles using plants or parts of the plants is also cost effective. The present study focuses on the biosynthesis of zinc oxide nanoparticles (ZnO NPs) using the seed extract of Butea monsoperma and their effect on to the quorum-mediated virulence factors of multidrug-resistant clinical isolates of Pseudomonas … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
34
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 58 publications
(37 citation statements)
references
References 43 publications
3
34
0
Order By: Relevance
“…The MIC of the AgNPs synthesized by strain MAHUQ-38 T against E. coli were much lower than some other antimicrobial agents, including biosynthesized CuO-NPs and ZnO-NPs which were 0.5 mg/mL and 8 mg/mL, respectively, against E. coli [ 26 , 27 ]. The MICs of the AgNPs synthesized by strain MAHUQ-38 T against P. aeruginosa were also significantly lower than some other antimicrobial agents, including biogenic nanoparticles, which were in the range 0.375–1.6 mg/mL against P. aeruginosa [ 28 , 29 ]. The MBCs of biosynthesized AgNPs for both E. coli and P. aeruginosa were 50 μg/mL ( Figure 10 ), which was also much lower than those of some other antimicrobial agents [ 26 , 27 , 28 ].…”
Section: Resultsmentioning
confidence: 99%
“…The MIC of the AgNPs synthesized by strain MAHUQ-38 T against E. coli were much lower than some other antimicrobial agents, including biosynthesized CuO-NPs and ZnO-NPs which were 0.5 mg/mL and 8 mg/mL, respectively, against E. coli [ 26 , 27 ]. The MICs of the AgNPs synthesized by strain MAHUQ-38 T against P. aeruginosa were also significantly lower than some other antimicrobial agents, including biogenic nanoparticles, which were in the range 0.375–1.6 mg/mL against P. aeruginosa [ 28 , 29 ]. The MBCs of biosynthesized AgNPs for both E. coli and P. aeruginosa were 50 μg/mL ( Figure 10 ), which was also much lower than those of some other antimicrobial agents [ 26 , 27 , 28 ].…”
Section: Resultsmentioning
confidence: 99%
“…ZnO NP mixtures at 25 nm (1600–3200 μg/mL) particularly had an antimicrobial activity against P. aeruginosa isolates from patients which were resistant to amikacin (30 μg), cefepime (30 μg), sparfloxacin (5 μg), piperacillin (100 μg), levofloxacin (5 μg), piperacilin-tazobactum (100/10 μg), imipenem (10 μg), tobramycin (10 μg), nitrofurantoin (300 μg), and ceftazidime (30 μg) [ 102 ].…”
Section: Antimicrobial Ctivity Against Pathogenic Microorganismsmentioning
confidence: 99%
“…Although, we could not test our fabricated nanofibrous membrane against P. aeruginosa. literature reports the effectiveness of both ZnO NP and OEO against this bacterium [ [53] , [54] , [55] , [56] ]. Many studies reported the effectiveness of OEO against multidrug resistance (MR) bacterial strain [ 57 ].…”
Section: Discussionmentioning
confidence: 99%